Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897935 · ClinicalTrials.gov registry record
Flare Photometry in Uveitis Patients
A clinical trial of Uveitis, sponsored by ChromoLogic.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT01897935: Completed study of Uveitis, sponsored by ChromoLogic.
NCT01897935 is a study of Uveitis that has completed, run by ChromoLogic. The registered enrollment target is 100 participants, below the 612-participant average among 19 other Uveitis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897935, a study of Uveitis, has completed, sponsored by ChromoLogic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM). Patients meeting the inclusion/exclusion criteria will receive a standard eye examination including a slit lamp examination to collect ocular flare data. In addition to the standard eye examination, subjects will receive flare measurements using the OFAM device.
Primary Outcome
OFAM algorithms for quantitation of ocular flare will be established by comparing the output of the OFAM device to the flare measurements obtained during the standard slit lamp examination.
Conditions Studied
Study Locations (1)
Washington
- UW Medicine Eye Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-04 |
What the finished NCT01897935 record still lists
NCT01897935 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 612-participant average among 19 other Uveitis trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Uveitis appearing as the primary indexed condition, and to 0 interventions.
NCT01897935 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01897935 about?
NCT01897935 is a clinical study titled "Flare Photometry in Uveitis Patients". This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM). Patients meeting the inclusion/exclusion criteria will receive a standard eye examination including a slit lamp examination to collect ocular flare data. In addition to the standard eye examination, subjects wil...
What is the current status of trial NCT01897935?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-06. Estimated completion is 2014-04.
What conditions does trial NCT01897935 study?
This clinical trial studies the following conditions: Uveitis.
Who is sponsoring clinical trial NCT01897935?
This trial is sponsored by ChromoLogic, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01897935 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01897935's enrollment target sits among peer trials
100 11th of 19 higher than 7 of 19 other Uveitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uveitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
RECRUITING
-
Genetics of Uveitis
RECRUITING
-
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
RECRUITING
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia